A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of Things

ConditionsHead and Neck Cancer Radiation-Induced Mucositis

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorNanfang Hospital, Southern Medical University

About this trial

This study is a researcher-initiated, multi-center, prospective, two-arm interventional randomized controlled study across the country. It aims to explore whether an Internet of Things-based RIS system can enhance the medical experience of patients with radiation-induced oropharyngeal mucositis during the diagnosis and treatment process among head and neck cancer patients undergoing radiotherapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Voluntarily sign the informed consent form;

Reached the age of 18 on the date of signing the informed consent form, and under the age of 65;

Patients diagnosed with head and neck tumors and receiving radiotherapy as per the 2017 WHO standards and guidelines.

According to the doctor's assessment, patients may experience radiation-induced oropharyngeal mucositis during radiotherapy.

Disqualifiers

Have other uncontrolled serious diseases, such as unstable heart diseases requiring treatment, poorly controlled diabetes (fasting blood sugar > 1.5 times the upper limit of the normal value), mental disorders, and a severe history of allergies.

Trial design

Design model

Parallel

Treatments tested in this trial

RIS system
Other intervention
The RIS system based on the Internet of Things consists of three aspects: one-way output management of the large database of head and neck tumors, two-way interaction management of artificial intelligence applications, and popular science dissemination for the general public.

Treatment groups

110 Participants

are divided into 2 treatment groups

Group A: experimental groupExperimental treatment 1 intervention

Group B: control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

the satisfaction of patients

We use the patient satisfaction scale designed by us for the information age to assess patients' satisfaction during the diagnosis and treatment period.

Time frame